Discover how GLP-1 medications impact exercise and body composition, and learn practical strategies to preserve muscle and support athletic performance.
On August 25, 2026, a comprehensive review cited by Men’s Journal detailed new findings regarding GLP-1 weight-management medications and their effects on physical performance. The publication highlighted the tension between medically assisted fat loss and the physiological demands of intense exercise. The central concern revolves around body composition rather than scale weight alone. A review cited by Men’s Journal estimates that roughly 25% to 40% of weight lost on GLP-1 drugs may come from fat-free mass.
This category includes muscle, water, and other lean tissues. A separate review similarly described lean-mass reductions of roughly 20% to 40% of total weight lost. The authors noted that these results vary significantly between people and individual studies. For adults focusing on long-term metabolic health, preserving strength and physical function often matters more than achieving the lowest possible scale weight.
To fully understand these outcomes, we must look at how these clinical treatments alter the body. GLP-1 medications reduce appetite and significantly slow digestion. This creates a profound shift in energy balance that is not simply a matter of willpower. Sustainable weight management involves a complex interaction of appetite signaling, nutrition, daily habits, and targeted medical treatments.
By making people feel full sooner, these medications help create the calorie deficit necessary for fat reduction. However, these same biological effects can make it difficult to consume adequate calories, carbohydrates, and protein. Delayed gastric emptying can make pre-exercise meals, mid-workout fueling, and post-workout recovery highly uncomfortable. When individuals combine an intense training schedule with a medically induced calorie deficit, they face serious energy availability problems.
Endurance coach Kylee Van Horn noted that combining intentional calorie restriction with high training volume creates a relative energy deficiency problem. The primary concern is that active individuals may unintentionally underfuel the biological work required to recover, adapt, and maintain muscle tissue. For people training five or more hours per week while also maintaining a calorie deficit, this lack of energy impacts normal physiological function. Potential consequences of inadequate fueling include poorer physical recovery, gastrointestinal problems, hormonal disturbances, and muscle loss.
Mainstream media coverage frequently warns that GLP-1 medications automatically destroy skeletal muscle. The available literature paints a more nuanced and less sensational picture. A decline in measured lean mass does not necessarily mean an equivalent decline in contractile skeletal muscle. Lean-mass measurements should be interpreted cautiously because they do not isolate skeletal muscle from all other lean tissues.
The notion that muscle loss is a unique, toxic side effect of these specific medications is also missing crucial context. A reported SURMOUNT-1 body-composition analysis found that approximately 75% of weight loss was fat mass and 25% was lean mass. Importantly, a similar proportion was observed in the placebo group. This suggests that some lean-mass reduction may accompany substantial weight loss generally.
It is not an exclusive penalty of the medication itself. Furthermore, claims that these drugs universally impair athletic performance go beyond the available evidence. The available literature has not yet established how GLP-1 medications affect competitive athletes’ performance. Reduced body mass can actually make walking, running, and cycling easier for people whose starting weight limits mobility.
The experiences described in Men’s Journal illustrate this exact trade-off. One cyclist and weightlifter reported becoming lighter, faster, and fitter overall while taking retatrutide. However, he also found that appetite suppression made it harder to fuel long rides. This lack of energy may have limited his ability to reach peak running performance.
To mitigate lean mass reduction, experts recommend deliberate nutritional and exercise interventions. Recent reviews and sports-nutrition guidance recommend combining adequate protein with regular resistance training. A 2026 sports-nutrition review proposed aiming for approximately 1.2–1.6 grams of protein per kilogram of body weight per day during active weight loss. This target should be paired with resistance exercise at least twice weekly.
Another review identified 1.2–1.6 grams per kilogram per day and structured resistance training as the best-established practical strategies for mitigating lean-mass loss. The Gatorade Sports Science Institute similarly recommends pairing approximately 1.2–1.6 grams of protein per kilogram per day with resistance training at least two days per week. They also encourage at least 150 minutes per week of moderate-to-vigorous physical activity. Men’s Journal notes a slightly different practical target of approximately 1 gram of protein per pound of ideal body weight.
Both frameworks emphasize that consuming enough protein is critical, but forcing down enough food can be difficult when appetite is markedly reduced. Tracking clinical outcomes is equally important for preserving physical function over time. In a 140-person STEP 1 DXA substudy, semaglutide treatment was associated with reductions in both fat mass and total lean mass over 68 weeks. Because these measurements cannot perfectly isolate skeletal muscle, individuals should monitor practical functional metrics.
Tracking strength, work capacity, and waist measurement provides a much clearer picture of true body composition changes. There are several practical steps adults can take to protect their physical capabilities while utilizing these medications.
Sports-nutrition guidance commonly recommends resistance training at least twice weekly while a person is losing weight on an incretin-based therapy. WeightRestart advocates for focusing on sustainable routines rather than exhaustive daily workouts. For a time-pressed adult, two brief full-body sessions may be far more sustainable than an ambitious program that repeatedly gets abandoned. Consistency is essential for understanding training adaptations and protecting your functional capacity.
Using protein targets as a planning tool is highly beneficial for preserving lean tissue. Published guidance commonly proposes approximately 1.2–1.6 grams per kilogram of body weight per day during active weight loss. Because medical histories and kidney health vary, this target should always be adapted with clinician advice. If large meals become difficult to digest, individuals should plan smaller, protein-containing meals using nutrient-dense foods.
If you are preparing for a major athletic event, aggressive calorie restriction can hinder your progress. Obesity-medicine physician Spencer Nadolsky advises against overlapping aggressive weight loss with an important race or fitness goal. The feature’s expert advice is to avoid intentional weight loss for roughly three months before a major fitness event. Adults preparing for a marathon or strength competition need to prioritize recovery and fueling over active fat loss.
Slowed digestion changes how the body handles mid-workout carbohydrates. Energy gels, large meals, or high-carbohydrate sports drinks may become much harder to tolerate for some users. Experts recommend testing alternative foods and fluid strategies during ordinary training sessions rather than waiting until race day. Persistent inability to eat enough, worsening fatigue, declining performance, or repeated gastrointestinal symptoms should prompt a conversation with a prescribing clinician.
Do not let appetite suppression become accidental starvation. When a person feels artificially full for long periods, it is easy to drastically under-eat. Individuals should focus on nutrient-dense, high-protein foods to make energy consumption easier. Keeping weights readily available at home can also make resistance exercise easier to sustain when overall energy levels fluctuate.
A successful outcome is about losing fat while maintaining or improving strength, work capacity, and daily energy. Weight regain can occur after discontinuation, and many patients are advised to use these medications long term. Maintenance planning must therefore include sustainable eating habits, resistance training, and regular medical follow-up. Individuals should focus on how exercise influences appetite and sustainable weight loss while taking a long-term view of their health.
Looking ahead, the medical and fitness communities need more robust data on long-term physical function. Future research must evaluate how these treatments interact with competitive athletic demands. Current athlete-specific evidence remains incredibly sparse, and controlled data on maximal strength and power output are limited. The industry is also investigating evolving areas of research, including activin- or myostatin-pathway treatments like bimagrumab.
The 2026 narrative review noted that early trials suggest possible lean-mass benefits, but these approaches remain purely investigational. Until new clinical protocols are fully verified, combining structured strength training with adequate nutrition remains the most reliable path for individuals utilizing sustainable weight management treatments.
WeightRestart shares research-led guidance on weight loss, metabolism, nutrition, strength, appetite, sleep and recovery. Our goal is to make complex health information clear, practical and useful for people building progress they can maintain.
Learn how to build a weight-management approach around better information, realistic expectations and habits you can keep using.
read the blog
